GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Institutional Ownership

Enzymotec (Enzymotec) Institutional Ownership : 51.18% (As of May. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Enzymotec's institutional ownership is 51.18%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Enzymotec's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Enzymotec's Float Percentage Of Total Shares Outstanding is 50.65%.


Enzymotec Institutional Ownership Historical Data

The historical data trend for Enzymotec's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Institutional Ownership Chart

Enzymotec Historical Data

The historical data trend for Enzymotec can be seen below:

2015-09-30 2015-12-31 2016-03-31 2016-06-30 2016-09-30 2016-12-31 2017-03-31 2017-06-30 2017-09-30 2017-12-31
Institutional Ownership 51.50 57.05 52.09 43.07 43.48 49.75 35.13 56.60 42.86 51.18

Enzymotec Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Enzymotec (Enzymotec) Business Description

Traded in Other Exchanges
N/A
Address
Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016